Steward Partners Investment Advisory’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Steward Partners Investment Advisory’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.9K	Hold	1,046	–	–	﹤0.01%	3081
2026 Q1	$35.9K	Sell	1,046 -29	-3%	-$991	﹤0.01%	2946
2025 Q4	$35.4K	Sell	1,075 -1	-0.1%	-$31	﹤0.01%	2855
2025 Q3	$30.7K	Sell	1,076 -1,650	-61%	-$44.9K	﹤0.01%	2877
2025 Q2	$69.9K	Sell	2,726 -684	-20%	-$17.3K	﹤0.01%	2297
2025 Q1	$93.7K	Sell	3,410 -4,847	-59%	-$134K	﹤0.01%	2050
2024 Q4	$223K	Sell	8,257 -9	-0.1%	-$253	﹤0.01%	1547
2024 Q3	$238K	Sell	8,266 -9,496	-53%	-$272K	﹤0.01%	1439
2024 Q2	$484K	Sell	17,762 -46,094	-72%	-$1.23M	0.01%	1078
2024 Q1	$1.79M	Buy	63,856 +8,887	+16%	+$245K	0.02%	612
2023 Q4	$1.46M	Sell	54,969 -1,703	-3%	-$42.9K	0.02%	601
2023 Q3	$1.45M	Buy	56,672 +41,569	+275%	+$1.1M	0.02%	550
2023 Q2	$395K	Sell	15,103 -67,540	-82%	-$1.78M	0.01%	1018
2023 Q1	$2.16M	Buy	82,643 +14,744	+22%	+$395K	0.03%	450
2022 Q4	$1.86M	Buy	67,899 +35,814	+112%	+$953K	0.03%	470
2022 Q3	$771K	Buy	32,085 +31,670	+7,631%	+$819K	0.01%	716
2022 Q2	$11K	Hold	415	–	–	﹤0.01%	2483
2022 Q1	$11K	Hold	415	–	–	﹤0.01%	2613
2021 Q4	$11K	Hold	415	–	–	﹤0.01%	2557
2021 Q3	$11K	Hold	415	–	–	﹤0.01%	2567
2021 Q2	$11K	Hold	415	–	–	﹤0.01%	5857
2021 Q1	$10.6K	Hold	415	–	–	﹤0.01%	2756
2020 Q4	$11K	Hold	415	–	–	﹤0.01%	2271
2020 Q3	$10K	Buy	+415	New	+$9.96K	﹤0.01%	2134

Other funds holding FTXH

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

MIM

Marshall Investment Management Littleton, Colorado $241M AUM 30.53% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Steward Partners Investment Advisory's FTXH Position: Q2 2026 in Review

Steward Partners Investment Advisory held its First Trust Nasdaq Pharmaceuticals ETF (FTXH) position steady in Q2 2026 at 1,046 shares worth $39.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3081.

Steward Partners Investment Advisory first reported a position in FTXH in Q3 2020 and has held it in 24 quarters since. The position peaked at $2.16M in Q1 2023. 31 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

Steward Partners Investment Advisory held 1,046 shares of First Trust Nasdaq Pharmaceuticals ETF worth $39.9K as of Q2 2026.
Steward Partners Investment Advisory left its First Trust Nasdaq Pharmaceuticals ETF share count unchanged in Q2 2026.
First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3081 holding.
Steward Partners Investment Advisory first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q3 2020 and has held it in 24 quarters since.
Steward Partners Investment Advisory's First Trust Nasdaq Pharmaceuticals ETF position peaked at $2.16M in Q1 2023.
31 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.